INTRODUCTION
The concept of Mild Cognitive Impairment (MCI) identifies an intermediate phase in the continuum physiological aging-dementia characterized by a slight cognitive impairment in patients that may proceed toward dementing illnesses (Petersen et al. 2014 ). MCI was introduced as a clinical entity in the 1980s, first systematized by Petersen et al. (1999) and then redefined by the International Work Group on MCI in a Key Symposium (Winblad et al. 2004) . From this last turnover, MCI became a broader construct than first thought and focused not only on amnestic deficits reported by patients but also on impairments in other cognitive domains rather than memory. Based on epidemiological longitudinal studies, the International Work Group on MCI argued that when patients with MCI were followed over time, some progress to Alzheimer's Disease (AD) or other dementing illnesses while others remain stable over time or revert to a normal cognitive status. Many studies have suggested that patients with amnestic MCI multiple domain are more likely to progress to AD whereas MCI patients with non-amnestic cognitive impairment may develop other conditions, such as frontotemporal dementia, vascular dementia, dementia with Levy bodies and even depression (Petersen et al. 2009 ). Amnestic MCI multiple domain (aMCI+) is considered the most frequent subtype among individuals with MCI and it has been recognized that episodic memory disorder along with executive functions deficits (especially in planning and inhibitory control) constitute the neuropsychological pattern with high risk of conversion into dementia (Petersen & Negash 2008 , Cammisuli et al. 2012 . Furthermore, the use of biomarkers may aid researchers in distinguishing MCI due to specific causes. The National Institute of Aging-Alzheimer's Associations (NIA-AA) aimed at developing criteria for the symptomatic pre-dementia stages of AD. They therefore redefined MCI criteria including two main sets of biomarkers that may help in formulating the clinical judgement of MCI due to AD (i.e. biomarkers of amyloid beta deposition and neuronal injury) with four levels of certainty depending on the presence and nature of biomarkers finding (Albert et al. 2011 ).
Contrary to the MCI construct, the Parkinson's Disease-Mild Cognitive Impairment (PD-MCI) construct is still recent dating back to 2012. According to the fact that PD is not only defined by characteristic motor hallmarks (i.e. rest tremor, bradykinesia, rigidity and gait impairment) but also by cognitive symptoms, the Movement Disorder Society (MDS) commissioned a task force to provide diagnostic criteria for PD-MCI, including guidelines for the assessment (i.e., Level I: abbreviated assessment and Level II: comprehensive assessment) and subtypes classification (Litvan et al. 2012; Geurtsen et al. 2014 , Hoogland et al. 2017 ).
In PD, there is a wide spectrum of cognitive dysfunction from MCI to Parkinson's Disease Dementia (PDD). MCI is quite common in non-demented PD patients occurring in about 20-50% of patients and it represents a risk factor for the conversion into PDD (Goldman & Litvan 2011) . PD-MCI patients usually report some difficulties in functional independence that may be reflected in the quality of life (Federico et al. 2015) . PD-MCI is associated to increasing age, low levels of education, later onset of the disease, greater PD severity, longer disease duration and it is more frequent in males than females (Palavra et al. 2013) .
Contrary to previous studies in literature, after the introduction of diagnostic criteria for PD-MCI (Litvan et al. 2012 ), more recent investigations have confirmed that multiple domain impairment seems to predominate in PD-MCI and executive deficits are the most frequent ones that commonly occur (Marras et al. 2013 ). Executive deficits in planning, sequencing, cognitive flexibility, problem-solving and working memory reflecting frontostriatal circuits dysfunction due to either degeneration of dopaminergic nigrostriatal or mesocortical pathways have been found in PD-MCI patients (Goldman & Litvan 2011; Williams-Gray et al. 2007 ). Moreover, further investigations have suggested even how memory deficits in PD-MCI may be mainly due to a primary executive dysfunction accounting for strategic encoding and recall difficulties (Weintraub et al. 2011 ). Impairments of selective and divided attention and inhibitory control have also been reported in PD-MCI (Aarsland et al. 2011 ). Finally, according to Biundo et al. (2016) an unsolved question regarding the nature and progression of language impairment in PD remains: while some authors suggested that language deficits occur with executive dysfunction or impairment of selective attention or even working memory, other authors showed the presence of specific linguistic deficits without concurrent executive dysfunction.
To date, only one study directly compared performances of PD-MCI patients versus aMCI+ patients for memory domain (Pistacchi et al. 2015 
SUBJECTS AND METHODS
Forty PD-MCI patients, forty aMCI+ patients and twenty-two controls constituted the sample of the study. (Winblad et al. 2004 ). The controls were community-dwelling volunteers from the Valdera (Pisa) area without impairment in neuropsychological tests and history of neurological or psychiatric diseases.
All the participants provided written informed consent before clinical examination and neuropsychological assessment. The study protocol was approved by the Ethic Committee of Area Vasta Nord Ovest (Pisa, Italy).
A score below 85.5 in the Milan Overall Dementia Assessment (MODA) (Brazzelli et al. 1994 ) was defined as the cut-off score for diagnosing a dementia syndrome for clinical groups in which Activities of Daily Living (Katz 1983) 
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RESULTS
The PD-MCI patients, the aMCI+ patients and controls were demographically matched in terms of age (PD-MCI vs aMCI+: t=1.323, p= n.s.; PD-MCI vs controls: t=1.624, p= n.s.; aMCI+ vs controls: t=1.041, p= n.s.), education (PD-MCI vs aMCI+: t=0.100, p= n.s., PD-MCI vs controls: t=0.018, p= n.s.; aMCI+ vs controls: t=-0.989, p= n.s.) and gender ( 2 =1.728, p=n.s.) ( Table 2 ). No significant difference was found among clinical groups on MODA total score (t=0.353; p=n.s.) while PD-MCI patients and aMCI+ significantly differenced from controls in such overall screening test (PD-MCI vs controls: t=-3.661, p=0.001; aMCI+ vs controls: t=-3.557, p=0.001), as expected. The KruskalWallice detected a significant performance difference for ADL and IADL among the three groups (p<0.001). Therefore, the Mann-Whitney U Test was performed and significant differences among the groups were found, as follows: PD-MCI vs controls for IADL (p=0.001), PD-MCI vs aMCI+ for ADL (p=0.001) and IADL (p=0.006). The other comparisons (i.e., PD-MCI vs controls for ADL; aMCI+ vs controls for ADL and IADL) did not show any significant difference (p= n.s.).
Descriptive analysis of the neuropsychological tests was provided (Table 3) .
The 
DISCUSSION
Although it is well known that PPD results in a functional decline, our findings confirm investigations on IADLs impairment also in PD-MCI (Pirogovsky et al. 2014 ) and the importance to add measures of day-today functioning in the clinical evaluation of this category of patients.
Our results demonstrate that attention/working memory and executive dysfunction is specific for PD-MCI and aMCI+ patients and that PD-MCI patients mostly present a major involvement of attention/working memory domain, as shown by the comparisons between groups performances on Digit Span and Stroop Test. The first is a test frequently used as a measure of phonological loop that is assumed to be responsible for maintaining verbal-based information in Baddeley's model of working memory (1992). In order to correctly perform Digit Span, PD-MCI patients would require more attentional resources and control processes than aMCI+ patients. The latter specifically reflects the ability to inhibit a dominant response and it has often been associated to anterior cingulate cortex (Gruber et al. 2002) . In comparison to aMCI+, PD-MCI patients show scarce performances in Stroop Test determined by the time needed to discard irrelevant but salient verbal information in favour of a less obvious aspect (i.e. colour naming), known as "interference effect" mostly related to committed errors (i.e. Interference/Error score) than time (i.e. Interference/Time score). Because of their greater inability to restrain interference, PD-MCI patients make more errors than aMCI+ patients in which an impairment of inhibitory control as such and regardless of errors has been shown, too (Traykov et al. 2007 ). Such results on Digit Span and on Stroop Interference/Error are corroborated by the significant differences between performances of PD-MCI patients and controls. However, PD-MCI patients and aMCI+ patients showed lower performances than controls on Stroop Interference/Time, by suggesting that inhibitory control represents a critical domain more frequently affected in mild cognitive disorders (cfr. Bélanger et al. 2010 ). Moreover, Santangelo et al. (2015) have recently suggested that among cognitive measures, the Stroop Test may be useful even for identifying patients at high risk of developing PD-MCI at the time of PD diagnosis, by suggesting that an impairment of inhibitory control might represent an early cognitive deterioration in the course of the disease.
The significant positive correlation between the Stroop Test and the Digit Span in PD-MCI group might be due to the involvement of some brain areas (i.e. left inferior frontal gyrus and anterior cingulate cortex) in activating conscious attention and mediating inhibitory control (Nee et al. 2007 ). These brain areas have been found to be of particular interest by neuroimaging studies investigating cognitive impairment in PD-MCI (Lee et al., 2014) . Moreover, significant correlations between scores obtained in Stroop Test and in some TOL DX sub-scores support that an underlying attention deficit is present in PD-MCI patients.
Finally, cognitive deficits in PD have been frequently attributed to neurochemical alteration in the dopaminergic system that is crucial for attention and working memory functioning associated to prefrontal Psychiatria Danubina, 2017; Vol. 29, No. 4, pp 437-445 areas (Pillon et al. 2003 ) instead of a reduced choline acetyltransferase activity in temporal and frontal lobes yielding episodic memory and executive impairment in aMCI+ patients developing AD (Brandt et al. 2009; Reinvang et al. 2012 ). Interestingly, despite slow psychomotor speed and resting tremor that may interfere with performance in tests requiring motor abilities such as TOL, PD-MCI patients do not show lower performances than aMCI+ in this test. PD-MCI patients significantly differed from controls in TOL DX Violation Time subtest, by suggesting a weakening of executive planning efficiency but not as severe as that reported by aMCI+ patients. The results of the aMCI+ group on this subtest is in line whit a previous study that pointed out how MCI decliners show a dysfunction in selfmonitoring/rule-bound control than stable MCI patients and controls (Rainville et al. 2012) . Total Initiation Time, which is the time from the presentation of a test problem by the examiner to the initiation of the first problem-solving move, is more damaged in aMCI+ than PD-MCI patients accounting for a more pronounced deficit in time assumed for planning accuracy/task analysis on the moves sequence. Such a result is corroborated by the significant difference between performances of aMCI+ patients and controls on this TOL DX sub-score. The cognitive planning component of executive problem-solving thought to be the central construct assessed by the TOL DX and brain activity during planning is mainly associated to prefrontal areas, particularly to dorsolateral prefrontal cortex (Lazeron et al. 2000) . Other constructs, such as procedural memory, which is recognized to decrease in PD, are considered to have a lesser effect on TOL DX performance (Riccio 2004) . Moreover, when compared to controls on Brixton Test, aMCI+ patients present a deficit of cognitive flexibility, which is recognized as a cognitive ability related to the above mentioned brain area (Chan et al. 2008 ). As expected, aMCI+ patients also present an episodic memory deficit, as shown by groups comparison on Prose Recall and on Pairs Associates Learning. In addition, they have a visual recognition decay, as shown by groups comparison on Street's Completion Test.
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Finally, our results highlight that naming is damaged in MCI groups when compared to controls on BNT. Such a result can contribute to clarify the relationship between language and executive impairment and specify the type of linguistic deficit occurring in PD-MCI.
CONCLUSIONS
In comparison to the previous investigation (Pistacchi et al. 2015) , we would stress that the present study represents a step forward in specifying the attention/working memory and executive profile of PD-MCI patients in comparison to aMCI+ ones and also contributes to an informative analysis of specificity and validity of the PD-MCI clinical entity. PD-MCI patients may present a defect of conscious attention and an inhibitory control deficit conversely to a scarce selfmonitoring/rule-bound and time assumed for planning accuracy that characterize aMCI+ patients. Such differences have been discussed according to neurochemical alterations and neural circuits differently involved in PD and AD.
Neurologists and neuropsychologists are likely to be managing an increasing number of PD-MCI patients in the near future. A reliable testing of attention/working memory and executive functions including Digit Span, Stroop Test, TOL DX should be integrated in clinical practice for the evaluation of MCI patients with different aetiologies.
Currently, non-pharmacological interventions have attracted increasing interest for enhancing cognitive functioning in PD patients without dementia. In the light of our findings, PD-MCI patients with a specific pattern of deterioration in attention/working memory domain should undergo cognitive training which researchers showed to be effective in maintaining and improving cognitive abilities. In a randomized control trial (Petrelli et al., 2014) , 65 patients with PD were allocated to one of two cognitive multi-component treatments (a structured training, named "NEUROvitalis" -NV-and a nonstructured one, named "Mentally Fit" -MF-, each including 12 group sessions of 90 minutes over 6 weeks) or a waiting list control group (CG). The NV includes individual tasks, group tasks and group games each focusing on specific cognitive functions (i.e., attention, memory, executive functions) whereas in MF cognitive domain training was not addressed in focus sections but over the course of the program and differently from NV. Compared to the CG, patients from NV group improved in short-term memory and working memory. Moreover, the NV group significantly improved more in working memory than MF group. With 1-year follow-up of 45 on 65 original patients (Petrelli et al. 2015) , researchers concluded that both cognitive trainings yield a stabilization of overall cognitive functions and a reduced risk of developing MCI.
Our study should be implemented by the collection of more extensive data to let researchers infer more robust conclusions and generalizability of the findings. Moreover, significant statistical differences of groups performances should be interpreted with caution. The use of ES allows the comparability among many neuropsychological tests adopting this kind of scoring net of age, sex and education. However, this statistical model presents some limitations due to large scoring categories (i.e. 0-4) that depend on tolerance limits and inferential error risk, sample size variability and the linear model used for adjusting scoring by considering the effects of age, sex and education.
